Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Cost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Interest Expenses (2016 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Interest Expenses over the past 15 years, most recently at $4.6 million for Q4 2024.

  • For Q4 2024, Interest Expenses rose 455.65% year-over-year to $4.6 million; the TTM value through May 2025 reached $9.0 million, up 163.21%, while the annual FY2024 figure was $3.4 million, 80.1% down from the prior year.
  • Interest Expenses for Q4 2024 was $4.6 million at Lifecore Biomedical, Inc. \De\, up from $4.4 million in the prior quarter.
  • Over five years, Interest Expenses peaked at $6.1 million in Q3 2021 and troughed at -$12.6 million in Q2 2022.
  • A 5-year average of $1.8 million and a median of $2.3 million in 2021 define the central range for Interest Expenses.
  • Biggest five-year swings in Interest Expenses: plummeted 641.01% in 2022 and later skyrocketed 455.65% in 2024.
  • Year by year, Interest Expenses stood at $1.6 million in 2020, then surged by 73.37% to $2.8 million in 2021, then surged by 30.39% to $3.6 million in 2022, then plummeted by 76.94% to $832000.0 in 2023, then skyrocketed by 455.65% to $4.6 million in 2024.
  • Business Quant data shows Interest Expenses for LFCR at $4.6 million in Q4 2024, $4.4 million in Q3 2024, and $882000.0 in Q2 2024.